No profile data available.
Artelo Biosciences, Inc. (ARTL) is a healthcare company in the obesity treatment pharmaceuticals industry, based in Solana Beach, United States, with about 7 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$12.88 million. Its market capitalization was $1.79 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. 11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications.
Artelo Biosciences reported $0 in revenue for fiscal year 2025.
$1.79 million as of October 9, 2026.
Listed companies of a similar size in the same industry (obesity treatment pharmaceuticals) include BioAge Labs, Inc. (BIOA), Aardvark Therapeutics, Inc. (AARD), Skye Bioscience, Inc. (SKYE).